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Introduction
Metabolic control is primarily regulated by the insulin signaling network. In healthy individuals, insulin stimulates glucose uptake from the bloodstream into adipose tissue and skeletal muscle while inhibiting glucose production in the liver. Dysregulation of this network associated with insulin resistance causes an increase in blood glucose and lipid levels, often initially associated with an increase in insulin levels and eventually culminating in type 2 diabetes (1) . Understanding the signaling network activated by insulin stimulation is crucial for identifying the causes and effects of network dysregulation and insulin resistance.
Insulin binds to the insulin receptor at the cell surface and activates its tyrosine kinase activity, leading to autophosphorylation and phosphorylation of several receptor substrates. Phosphorylation of selected tyrosine sites on receptor substrates are known to activate different pathways leading to increased glucose uptake, lipogenesis, and glycogen and protein synthesis , as well as to stimulation of cell growth (1; 2) . In addition to activation of these pathways by tyrosine phosphorylation, several mechanisms of downregulating the response to insulin stimulation have also been identified. For instance, serine phosphorylation on IRS-1 induced by a variety of factors has been shown to interfere with the activating effects of tyrosine phosphorylation, by decreasing binding to the insulin receptor or increasing degradation of IRS-1(1; 3; 4). Ser/Thr phosphorylation of the insulin receptor has also been shown to decrease tyrosine kinase activity (1) . Downregulation of the insulin receptor (1) and IRS-1 (3) are two additional mechanisms of mediating insulin resistance. Many of these factors are reflected in decreased amounts of the tyrosine phosphorylated receptor and receptor substrates with concomitant reduction in downstream signaling. Even though tyrosine phosphorylation plays a key role in insulin signaling, rather limited knowledge of specific phosphorylation sites, mainly focusing on tyrosine phosphorylation on the insulin receptor and IRS-1, is available so far. Therefore, we expected that a more comprehensive analysis of tyrosine phosphorylation upon insulin stimulation would lead to further insights into the biology of the signaling network.
We have recently developed a mass spectrometric methodology for the identification and quantification of tyrosine phosphorylation sites on many proteins (5). Here we have applied this methodology to the analysis of insulin signaling in 3T3-L1 adipocytes stimulated with insulin for 0, 5, 15, or 45 minutes. Using this approach, we were able to identify and quantify the temporal dynamics of many previously described sites on the insulin receptor and several insulin receptor substrates, as well as many additional sites, both previously characterized and novel, on other proteins associated with insulin signaling. These include sites related to the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways. Moreover, this analysis also produced temporal phosphorylation profiles for a number of novel phosphorylation sites on proteins which have, so far, not been directly associated with insulin signaling, such as proteins in the machinery of GLUT4 trafficking. The results of this study show that the insulin-elicited increase in tyrosine phosphorylation is more widespread than previously known, and identify many new sites to be explored for their specific roles in insulin action.
Materials and Methods
Cell culture, insulin stimulation and cell lysis 3T3-L1 fibroblasts from the American Type Culture Collection were carried as fibroblasts and differentiated into adipocytes, as described previously (6) . Confluent 10-cm plates of adipocytes at day 7 after differentiation (~1x10 7 cells per 10 cm plate) were washed with serum-free DMEM and incubated in serum-free DMEM with 1 mg/ml bovine serum albumin for 16 hours. Cells were then stimulated with 150 nM insulin in this medium for 5 min, 15 min and 45 min; non-treated cells were used as 0 min time point. For every time point, 3 plates were prepared. After rinsing with PBS, cells were lysed in 1.5 ml 8 M urea containing 1 mM Na 3 VO 4 (7) ; the cell lysate was frozen in liquid nitrogen and stored at -70°C until further use.
Sample processing and peptide immunoprecipitation
Protein concentration was determined by BCA assay (Pierce). Proteins were reduced, alkylated and digested with modified trypsin (Promega, enzyme:substrate ratio 1:50) (5).
The digest was acidified to pH 2 with HCl, centrifuged, and the supernatant was filtered (Millex-HV filter, 0.45 µm pore size, Millipore), desalted and fractionated on a C18 SepPak Plus Cartridge (Waters) . Peptides eluted with 25% acetonitrile in 0.1% acetic acid were lyophilized, labeled with iTRAQ (1/4 plate per condition), combined, and phosphotyrosine (pTyr) peptide immunoprecipitation was performed with anti-pTyr antibodies as previously described (5), in 30 mM TrisCl, 30 mM NaCl pH 7.4 containing 0.4% Nonidet P40 Substitute (Fluka). For peptide immunoprecipitation, a mixture of PTyr-100 (Cell Signaling #9411, 18 µg) and PT-66 (Sigma P3300, 12 µg), previously coupled to Protein G Plus-Agarose beads (Calbiochem, 20 µl) was used, with the peptides derived from one 10-cm plate in 0.45 ml. Bound peptides were eluted from the antibody with 70 µl glycine 100 mM, pH 2.1.
Chromatography and LC-MS/MS
Since peptide immunoprecipitation with pan-specific anti-phosphotyrosine antibodies is subject to non-specific binding (specifically, those peptides containing aromatic amino acids (e.g. tyrosine, phenylalanine, tryptophan) appear to be preferentially enriched), further enrichment for phosphopeptides was performed using immobilized metal affinity chromatography (IMAC), as previously described (5) . This tandem affinity strategy virtually eliminated non-specifically retained peptides, such that almost all peptides in the final analysis contained phosphorylated tyrosine. Phosphopeptides were eluted from the IMAC column to a capillary precolumn (100 µm I.D., packed with 10 µm ODS-A (Kanematsu)), which was then connected to a capillary analytical column (50 µm I.D. 
Phosphopeptide Sequencing and Quantitative Analysis
MS/MS spectra were extracted and searched against rodent (mouse and rat) protein database (NCBI) using ProQuant (Applied Biosystems) as described previously (5 Table   1 ). Finally, all data were normalized by the 5 min sample.
The complete analysis of tyrosine phosphorylation was performed as described above three separate times, starting with lysates from separate 10-cm plates.
Results

Overview of insulin-elicited tyrosine phosphorylation
To quantify temporal dynamics of tyrosine phosphorylation in the insulin signaling network, we have immunoprecipitated stable isotope coded, tyrosine phosphorylated peptides from 3T3-L1 adipocytes stimulated with insulin for either 0, 5, 15 or 45 minutes ( Figure 1 ). IMAC-LC-MS/MS analysis of the immunoprecipitated samples generated quantitative, temporal phosphorylation profiles for 126 peptides from 89 proteins. More than 80% of the peptides were quantified from at least two of the three biological replicates with an average standard deviation of 10% for the three analyses (see supplementary material, Table 2 ).
All the sites identified and quantified in this study are listed in Table 1 according to their changes in phosphorylation after 5 min insulin stimulation relative to control (no insulin stimulation). Table 2 of the supplementary material provides a complete presentation of the data. In the description of the results given below, if the supporting data is not presented in a table or figure it can be found in Table 1 of the text and/or Especially notable in the dataset are 12 peptides that increased in phosphorylation by greater than 10-fold following 5 minutes of insulin stimulation (Table 2 ). These included all the peptides containing sites identified on the insulin receptor itself. In addition, several sites on proteins related to the MAPK pathway were found in this group: Y1171
on IRS-1 and Y660 on GRB2-associated binding protein (Gab) 1, two sites with very similar sequences (pYI/LDLDL) that bind the tyrosine phosphatase SHP-2 and thereby participate in activation of the MAPK pathway (9; 10), Y53 on Sprouty4, a site known to have inhibitory effect on MAPK activation (11); and the doubly phosphorylated (T202 and Y204, T185 and Y187), active forms of extracellular signal-regulated kinase (ERK) 1 and 2 (12) . Three other phosphorylation sites were also found to have greater than 10-fold increase in phosphorylation: Y618 on APS, an adaptor protein linking the insulin receptor to Cbl binding (13); Y521 on Munc18c, a novel site on this protein which is involved in the fusion of GLUT4 vesicles with the plasma membrane (14) ; and Y1640 on Cdc42bpb, a novel site on this serine kinase, which may act as a downstream effector of Cdc42 in cytoskeleton reorganization (15) . In the following sections we describe in more detail various sets of tyrosine phosphorylation sites.
The head of the pathway: insulin receptor and substrates of the insulin receptor
Following ligand binding, the insulin receptor autophosphorylates on selected tyrosine residues, increasing kinase activity and recruiting adaptor proteins and substrates. We detected the singly and doubly phosphorylated forms of the catalytic loop of the kinase domain (including Y1175, 1179, 1180) with strong increase in phosphorylation up to 5 min and slight decrease to 45 min. In vitro, the triply phosphorylated form has been reported to lead to full activation of the phosphotransferase activity; however, in vivo, the doubly phosphorylated form was found to be the major form (16) . The C-terminal tyrosines 1345 and 1351 were also identified to be phosphorylated with a time-profile comparable to the sites in the catalytic loop. Those two sites have been reported to be involved in the regulation of the phosphotransferase activity of the insulin receptor (17) .
IRS-1, IRS-2, Src homology 2 domain containing transforming protein C (SHC), Gab1, and APS are insulin receptor substrate/scaffolding proteins, the tyrosine phosphorylation of which connects the activation of the insulin receptor to specific pathways (1; 2; 10; 18; 19). Mouse knockouts of IRS-1 and IRS-2 have marked phenotypes that show these two IRS's play particularly prominent roles in insulin signaling (20) . As expected, insulin caused a marked increase in the phosphorylation of one or more tyrosines on each of these substrate/scaffolding proteins. In the case of IRS-1, we were able to monitor the phosphorylation of 4 (Y460, Y935, Y983, Y1171) of the 10 tyrosine phosphorylation sites previously reported for mouse, rat, or human IRS-1 (PhosphoSite). Three of the sites were in the pYXXM motif, which is known to bind to the SH2 domains of the regulatory subunit of PI3K, and, as noted above, the fourth (Y1171) is a binding site for SHP-2 (10). They all showed maximal phosphorylation after 5 min insulin stimulation followed by a slight decrease with longer insulin stimulation.
The peptide containing phosphorylation of Y460 demonstrated a greater decrease (to about 50% of maximum level), which was most likely due to the appearance of the doubly phosphorylated form (T448/Y460) with maximum intensity after 15 min stimulation. The T448 site has not previously been reported and its function is not known. However, as noted in the Introduction, there are many phosphorylation sites on serine residues of IRS-1 which have been shown to alter its extent of tyrosine phosphorylation (3; 4).
In the case of IRS-2, we identified and quantified 6 tyrosine phosphorylation sites:
Y594, Y628, Y649, Y671, Y734, Y758, and Y814. Remarkably, although the sites of tyrosine phosphorylation on IRS-2 have been inferred by comparison to those on IRS-1 (21), to our knowledge they have not been previously determined. All but one of these sites is in the motif pYXXM, which binds to SH2 domains of the regulatory subunit of PI3K. For all of them with exception of Y671, phosphorylation increased more than 2-fold from 0 min to 5 min followed by mostly constant levels up to 45 min. Y671 showed only slight increase from 0 to 5 min and Y734 decreased slightly from 5 to 45 minutes.
However, the peptide containing Y734 was also observed in the doubly phosphorylated form with a serine phosphorylation at position 727 or 728; the doubly phosphorylated peptide slightly increased (20%) from 5 to 45 min, potentially offsetting the decrease of the singly phosphorylated form. As described above, two other substrate/scaffolding proteins, Gab1 and APS showed a marked increase in tyrosine phosphorylation. In addition, there was an 8-fold increase in the tyrosine phosphorylation of SHC, which generates a motif that binds to the adaptor protein Grb2 and contributes to activation of the MAPK pathway (22) .
Proteins associated with the insulin receptor and/or the IRS's
In addition to the substrates of the insulin receptor described above, insulin treatment caused increases in tyrosine phosphorylation on a number of other proteins known to be associated with the insulin receptor and/or its scaffolding substrates and to participate in Finally, in contrast to the other proteins in this section, the Src family tyrosine kinase
Fyn, which associates with tyrosine phosphorylated IRS-1 (32), underwent a 40% decrease in phosphorylation on Y417 over the 45 min of insulin exposure. This site is due to autophosphorylation and increases kinase activity (33), so dephosphorylation may be associated with reduced Fyn kinase activity a .
( a The peptide containing this site is also found in three other Src tyrosine kinase family members, Yes, Src and Lck.
We have assigned this site to Fyn based on previous reports linking Fyn to IRS-1, but it is possible that the quantification of this site may reflect the sum total of these Src family members.)
Other known insulin-elicited phosphotyrosine proteins in adipocytes
Among the pTyr proteins, there is a group that have previously been identified as undergoing insulin-stimulated tyrosine phosphorylation in adipocytes, but whose roles in signaling, if any, are less clear. This group consists of caveolin 1 and 2 (34; 35), PTRF (36), Syncrip (37), and fatty acid binding protein 4 (also known as aP2) (38). Caveolin 1 and 2 and PTRF are major protein components of the caveolar regions in the plasma membrane, which also contain insulin receptors (34; 39). In this regard, we also found a novel insulin-elicited phosphorylation on another caveolar protein, known as sdr. Sdr has previously been found to be the protein in caveolae that binds protein kinase C (40).
The sites of insulin-stimulated phosphorylation on caveolin 1/2 and fatty acid binding protein 4, but not those on PTRF and Syncrip, have been previously identified.
Proteins not previously associated with the insulin signaling network
In addition to the many proteins and phosphorylation sites which have been associated with insulin signaling, a substantial portion of the phosphorylation sites are on proteins that have not previously been reported to be directly involved in insulin signaling. In this section, we describe some, but not all, of these.
A major effect of insulin in adipocytes is the stimulation of glucose transport. The basis for this effect is the rapid introduction of additional glucose transporters of the GLUT4 type into the plasma membrane in response to insulin. The latter is achieved via the insulin-triggered movement of specialized intracellular vesicles containing GLUT4 to the plasma membrane and their fusion therewith (41). This process is referred to as GLUT4 translocation. Thus, it is of considerable interest that we found four proteins previously implicated in GLUT 4 translocation, Syntaxin4, Munc18c, EH domain-containing protein 2 (EHD2), and Annexin II, to be tyrosine phosphorylated in response to insulin (Table 1, Figure 2 ). Syntaxin4 is the plasma membrane snare protein that associates with the snare VAMP2 on GLUT4 vesicles (41). Munc18c associates with syntaxin4 and thereby may inhibit the binding of GLUT4 vesicles to syntaxin4 in the absence of insulin (14) .
EHD2 has been found to associate with GLUT4 (42), and it participates in GLUT4 endocytosis (43). Annexin II appears to be involved in GLUT4 translocation in a way that is not yet defined (44). Current evidence indicates that the signaling pathway to GLUT4 translocation proceeds from the insulin receptor through PI3K and the serine kinase Akt, which is not known to stimulate any tyrosine kinase (45). Thus, it is unclear whether any of these tyrosine phosphorylation sites are part of the signaling network leading to GLUT4 translocation, but because they are on proteins of the trafficking machinery, they deserve consideration.
Two transporters, a K-Cl cotransporter (Slc12a4) and an amino acid transporter (Slc38a2, SAT2), were tyrosine phosphorylated in response to insulin. Insulin has been reported to stimulate both of these transport systems. However, in the case of the K-Cl transporter, the basis for the stimulation appears to be an increase in transporter mRNA (46); and in the case of the amino acid transporter, translocation from an internal source, similar to that for GLUT4, has been found to underlie the stimulation (47). It may be that tyrosine phosphorylation also contributes to the stimulation.
A group of four of the stimulated pTyr proteins may participate in adhesions between adipocytes. These are three membrane-associated guanylate kinases (MPP1, MPP7, and SAP102), members of a family of proteins known to be involved in cell-cell adhesion (48), and the adipocyte adhesion protein (ASP5), a transmembrane protein that has been shown to participate in cell aggregation (49) . Thus, it is possible that insulin treatment may alter the adipocyte/adipocyte interactions. It is interesting that sites with similar temporal profiles appear to group together in modules within the signaling network. We have made the same observation in the EGF receptor signaling network (5) . Such temporal analysis has the potential to reveal functions for previously uncharacterized sites and proteins.
Temporal dynamics of phosphorylation in response to insulin stimulation
Discussion
This study is, to date, the most comprehensive analysis of the effect of insulin stimulation on site-specific protein tyrosine phosphorylation. We chose to use 3T3-L1
adipocytes for the analysis, since this cell type has been extensively studied, is highly insulin-responsive, and is a model for the animal fat cell. Cells were continuously further characterization of these novel sites and proteins will result in a significant expansion of our knowledge of the insulin signaling network.
In the future, application of this approach to the investigation of insulin signaling in various tissues of normal and diabetic mice, such as adipose tissue, muscle, and liver, will be a powerful approach to identify tissue-specific sites of tyrosine phosphorylation and the specific alterations in tyrosine phosphorylation in the diabetic state. 
* Sites from peptides resulting from more than one protein, based on NCBI mouse database. 
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